DOJ Civil Division on X: "Pharmaceutical Company Ultragenyx Agrees to Pay $6 Million for Allegedly Paying Kickbacks to Induce Claims for Its Drug Crysvita https://t.co/Zx3qbY0FcH https://t.co/qhCWcKvyDM" / X
PANTHERx® Rare Pharmacy Selected by Ultragenyx Pharmaceutical to Distribute DOJOLVI™ (triheptanoin), for Patients with Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) - PANTHERx Rare
Ultragenyx Enters into Strategic Partnership with Daiichi Sankyo for Gene Therapy Manufacturing Technology | World Pharma Today
GeneTx and Ultragenyx Announce Investigational New Drug
Ultragenyx Pharmaceutical, Inc. Aktie News
Update from Dr. Alison Skrinar on the Ultragenyx trials, Orbit and Cosmic – OI Foundation
Press releases—Ultragenyx Pharmaceutical Inc.
Press releases—Ultragenyx Pharmaceutical Inc.
Ultragenyx Fights for Cures Amid Rising R&D Costs - NAM
Foundation for Angelman Syndrome Therapeutics | FAST
GeneTx and Ultragenyx Announce Investigational New Drug
Ultragenyx Signs a License Agreement with Mereo for Setrusumab in Osteogenesis Imperfecta
Marin County's Ultragenyx Pharmaceutical reports Q2 loss of nearly $160 million
FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS (FAST) ANNOUNCES SALE OF ITS SHARES IN GENETX TO ULTRAGENYX
Ultragenyx Pharmaceutical Inc. (RARE) Stock Price, Quote & News - Stock Analysis
Ultragenyx Issues 2022 ESG Report, Continuing To Enhance Its Leadership on Corporate Responsibility
Ultragenyx Pharmaceutical Inc.
Articles about Ultragenyx Pharmaceutical Inc.
Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular Dystrophy - CureDuchenne
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Marin County's Ultragenyx Pharmaceutical estimates sales grew nearly 20% in 2023
Events & presentations—Ultragenyx Pharmaceutical Inc.
Investors & Media—Ultragenyx Pharmaceutical Inc.
Events & presentations—Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Development Pipeline – Angelman Syndrome Foundation
